id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-N-0449-0004,FDA,FDA-2004-N-0449,OMB Changes re: Current Good Manufacturing Practice for Positron Emission Tomography Drugs; Final Rule 74FR65409,Supporting & Related Material,Background Material,2010-04-27T04:00:00Z,2010,4,,,2015-12-10T15:26:23Z,,0,0,0900006480ae15f4
FDA-2004-N-0449-0003,FDA,FDA-2004-N-0449,Current Good Manufacturing Practice for Positron Emission Tomography Drugs; Final Rule,Notice,Notice of Final Rule,2009-12-10T05:00:00Z,2009,12,2009-12-10T05:00:00Z,,2015-12-10T15:21:51Z,E9-29285,0,0,0900006480a6840e
FDA-2004-N-0449-0002,FDA,FDA-2004-N-0449,OMB Review re: Current Good Manufacturing Practices for Positron Emission Tomography; Proposed rule 70FR55038,Supporting & Related Material,Background Material,2006-04-26T04:00:00Z,2006,4,,,2015-12-10T15:32:20Z,,0,0,0900006480475376
FDA-2004-N-0449-0001,FDA,FDA-2004-N-0449,Current Good Manufacturing Practice for Positron Emission Tomography Drugs; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2005-09-20T04:00:00Z,2005,9,2005-09-15T04:00:00Z,2005-12-20T04:59:59Z,2015-12-10T22:01:03Z,,0,0,0900006480475320